Acute Heart Failure Congestion and Perfusion Status – Impact of the Clinical Classification on in-Hospital and Long-Term Outcomes; Insights from the ESC-EORP-HFA Heart Failure Long-Term Registry
Ovidiu Chioncel(Carol Davila University of Medicine and Pharmacy), Lars H. Lund(Karolinska University Hospital), María G. Crespo‐Leiro(Complexo Hospitalario Universitario A Coruña), Gerasimos Filippatos(National and Kapodistrian University of Athens), Andrew J.S. Coats(The Heart Research Institute), Mitja Lainščak, Petar Seferović, Alexandre Mebazaa(Marqueurs cardiovasculaires en situation de stress), Massimo Piepoli(University of Milan), Aldo P. Maggioni(Health Care Foundation), Giuseppe M.C. Rosano(Università degli studi di Cassino e del Lazio Meridionale), Cécile Laroche(European Society of Cardiology), Frank Ruschitzka(Kantonsspital St. Gallen), Veli‐Pekka Harjola(Polskie Towarzystwo Gastroenterologii), Piotr Ponikowski(Wroclaw Medical University)
Cited by 352
Related Papers
2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure
|European Heart Journal|2021|13.1k
ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC
|European Heart Journal|2012|6.9k
Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction
|New England Journal of Medicine|2019|6.8k
2016 European Guidelines on cardiovascular disease prevention in clinical practice
|European Heart Journal|2016|6.5k
2016 ESC Guidelines for the Diagnosis and Treatment of Acute and Chronic Heart Failure
|European Journal of Heart Failure|2016|5.9k